Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Brain distribution of a panel of EGFR inhibitors using cassette-dosing in wild-type and Abcb1/Abcg2 deficient mice.

Kim M, Laramy JK, Mohammad AS, Talele S, Fisher J, Sarkaria JN, Elmquist WF.

Drug Metab Dispos. 2019 Jan 31. pii: dmd.118.084210. doi: 10.1124/dmd.118.084210. [Epub ahead of print]

2.

Brain Distribution and Active Efflux of Three panRAF Inhibitors: Considerations in the Treatment of Melanoma Brain Metastases.

Gampa G, Kim M, Mohammad AS, Parrish KE, Mladek AC, Sarkaria JN, Elmquist WF.

J Pharmacol Exp Ther. 2019 Mar;368(3):446-461. doi: 10.1124/jpet.118.253708. Epub 2019 Jan 8.

PMID:
30622172
3.

Permeability changes and effect of chemotherapy in brain adjacent to tumor in an experimental model of metastatic brain tumor from breast cancer.

Mohammad AS, Adkins CE, Shah N, Aljammal R, Griffith JIG, Tallman RM, Jarrell KL, Lockman PR.

BMC Cancer. 2018 Dec 7;18(1):1225. doi: 10.1186/s12885-018-5115-x.

4.

Insomnia in hospitalized psychiatric patients: prevalence and associated factors.

Talih F, Ajaltouni J, Ghandour H, Abu-Mohammad AS, Kobeissy F.

Neuropsychiatr Dis Treat. 2018 Apr 10;14:969-975. doi: 10.2147/NDT.S160742. eCollection 2018.

5.

Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases.

Shah N, Mohammad AS, Saralkar P, Sprowls SA, Vickers SD, John D, Tallman RM, Lucke-Wold BP, Jarrell KE, Pinti M, Nolan RL, Lockman PR.

Pharmacol Res. 2018 Jun;132:47-68. doi: 10.1016/j.phrs.2018.03.021. Epub 2018 Mar 28. Review.

PMID:
29604436
6.

Liposomal Irinotecan Accumulates in Metastatic Lesions, Crosses the Blood-Tumor Barrier (BTB), and Prolongs Survival in an Experimental Model of Brain Metastases of Triple Negative Breast Cancer.

Mohammad AS, Griffith JI, Adkins CE, Shah N, Sechrest E, Dolan EL, Terrell-Hall TB, Hendriks BS, Lee H, Lockman PR.

Pharm Res. 2018 Jan 9;35(2):31. doi: 10.1007/s11095-017-2278-0.

7.

A mouse Model of Focal Vascular Injury Induces Astrocyte Reactivity, Tau Oligomers, and Aberrant Behavior.

Logsdon AF, Lucke-Wold BP, Turner RC, Li X, Adkins CE, Mohammad AS, Huber JD, Rosen CL, Lockman PR.

Arch Neurosci. 2017 Apr;4(2). pii: e44254. Epub 2017 Apr 30.

8.

Cutaneous Horn Arising From a Burn Scar: A Case Report and Review of Literature.

Al-Zacko SM, Mohammad AS.

J Burn Care Res. 2018 Jan 1;39(1):168-170. doi: 10.1097/BCR.0000000000000559.

PMID:
28368921
9.

Quantitative Fluorescence Microscopy Measures Vascular Pore Size in Primary and Metastatic Brain Tumors.

Mittapalli RK, Adkins CE, Bohn KA, Mohammad AS, Lockman JA, Lockman PR.

Cancer Res. 2017 Jan 15;77(2):238-246. doi: 10.1158/0008-5472.CAN-16-1711. Epub 2016 Nov 4.

10.

Alterations in Pericyte Subpopulations Are Associated with Elevated Blood-Tumor Barrier Permeability in Experimental Brain Metastasis of Breast Cancer.

Lyle LT, Lockman PR, Adkins CE, Mohammad AS, Sechrest E, Hua E, Palmieri D, Liewehr DJ, Steinberg SM, Kloc W, Izycka-Swieszewska E, Duchnowska R, Nayyar N, Brastianos PK, Steeg PS, Gril B.

Clin Cancer Res. 2016 Nov 1;22(21):5287-5299. Epub 2016 May 31.

11.
12.

Semi-automated rapid quantification of brain vessel density utilizing fluorescent microscopy.

Bohn KA, Adkins CE, Mittapalli RK, Terrell-Hall TB, Mohammad AS, Shah N, Dolan EL, Nounou MI, Lockman PR.

J Neurosci Methods. 2016 Sep 1;270:124-131. doi: 10.1016/j.jneumeth.2016.06.012. Epub 2016 Jun 16.

13.

Characterization of passive permeability at the blood-tumor barrier in five preclinical models of brain metastases of breast cancer.

Adkins CE, Mohammad AS, Terrell-Hall TB, Dolan EL, Shah N, Sechrest E, Griffith J, Lockman PR.

Clin Exp Metastasis. 2016 Apr;33(4):373-83. doi: 10.1007/s10585-016-9784-z. Epub 2016 Mar 5.

14.

NKTR-102 Efficacy versus irinotecan in a mouse model of brain metastases of breast cancer.

Adkins CE, Nounou MI, Hye T, Mohammad AS, Terrell-Hall T, Mohan NK, Eldon MA, Hoch U, Lockman PR.

BMC Cancer. 2015 Oct 13;15:685. doi: 10.1186/s12885-015-1672-4.

15.

Molecular determinants of blood-brain barrier permeation.

Geldenhuys WJ, Mohammad AS, Adkins CE, Lockman PR.

Ther Deliv. 2015;6(8):961-71. doi: 10.4155/tde.15.32. Epub 2015 Aug 25. Review.

16.

Pediatric burns in Mosul: an epidemiological study.

Al-Zacko SM, Zubeer HG, Mohammad AS.

Ann Burns Fire Disasters. 2014 Jun 30;27(2):70-5.

17.

A novel preclinical method to quantitatively evaluate early-stage metastatic events at the murine blood-brain barrier.

Adkins CE, Nounou MI, Mittapalli RK, Terrell-Hall TB, Mohammad AS, Jagannathan R, Lockman PR.

Cancer Prev Res (Phila). 2015 Jan;8(1):68-76. doi: 10.1158/1940-6207.CAPR-14-0225. Epub 2014 Oct 27.

18.

Novel treatment strategies for brain tumors and metastases.

El-Habashy SE, Nazief AM, Adkins CE, Wen MM, El-Kamel AH, Hamdan AM, Hanafy AS, Terrell TO, Mohammad AS, Lockman PR, Nounou MI.

Pharm Pat Anal. 2014 May;3(3):279-96. doi: 10.4155/ppa.14.19. Review.

19.

P-glycoprotein mediated efflux limits substrate and drug uptake in a preclinical brain metastases of breast cancer model.

Adkins CE, Mittapalli RK, Manda VK, Nounou MI, Mohammad AS, Terrell TB, Bohn KA, Yasemin C, Grothe TR, Lockman JA, Lockman PR.

Front Pharmacol. 2013 Nov 4;4:136. doi: 10.3389/fphar.2013.00136. eCollection 2013.

20.

Monitoring pupils during a neurosurgical transfer.

Mohammad AS, Zafar N.

Anaesthesia. 2008 Jun;63(6):679; author reply 679-80. doi: 10.1111/j.1365-2044.2008.05556_1.x. No abstract available.

21.

Thyroid function in Kuwaiti subjects with Down's syndrome.

Ali FE, Bayoumy HA, Mohammad AS, Al-Busairi WA, Al-Othman AN.

Med Princ Pract. 2002 Oct-Dec;11(4):206-9.

22.

Quantitative effect of family planning programme in India (1965-76).

Mohammad AS, Jha SS.

Indian J Public Health. 1981 Jul-Sep;25(3):111-6.

PMID:
7347319
23.

Statistics & Ventreal Diseases.

Mohammad AS, Hossain T.

Indian J Dermatol Venereol. 1971 Nov-Dec;37(6):214-222. No abstract available.

Supplemental Content

Loading ...
Support Center